2023-01-02Chris Jacobs’ purchase of IVERIC Bio ( $ISEE ) on July 18th.Since then, the stock has risen over 92% as the biopharmaceutical company has announced positive data from their clinical trial and received a favorable designation from the FDA.Tweet not foundThe embedded tweet could not be found…Back To Buzz
PoliticianView Profile Chris JacobsRepublicanHouseNY Trades207 Issuers113 Volume4.27M IVERIC BIO INCISEE:US buy2022-10-12 1K–15K IVERIC BIO INCISEE:US buy2022-07-18 1K–15K
Related Reading2023-10-11Lawmakers could reap profits in stock from ongoing war in the Middle East2023-10-02Five Stocks That Dominated the Movement Charts2023-05-12Plug Power Falls on Weak FY Forecast2023-04-03Tesla Rally Pauses After Q1 Deliveries and Production Report2023-03-10Silvergate Capital to liquidate 4 months after Rep. Jacobs' sale
Since then, the stock has risen over 92% as the biopharmaceutical company has announced positive data from their clinical trial and received a favorable designation from the FDA.